Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insider Buying Shines Spotlight on 3 Stocks That Look Cheap

Page 1 of 3

The question most investors do not have an answer to is whether the recent downfall in U.S equities will be short-lived or will mark the beginning of a longer-term bear market. The Dow Jones Industrial Average and the S&P 500 Index are in correction territory at the moment, after declining by approximately 8% since the beginning of the year. It appears that both individual and larger-scale investors are afraid of a stock market meltdown similar to the one experienced back in 2007, so they want to get out of equities as quickly as possible. Yes, there are several reasons investors should worry, which include the sustained decline in energy prices, a relatively strong U.S dollar, and sluggish global economic growth. But it all comes down to the ability of the U.S economy to keep growing in the face of numerous headwinds. Meanwhile, several publicly-traded companies witnessed noteworthy insider purchases recently, which could point to attractive investment opportunities. As a general rule, insider buying should be perceived as a bullish signal, as an insider is not going to invest his or her hard-earned capital in their company’s stock without expecting an attractive return, especially at the risk of being less diversified. So let’s proceed with the discussion of the insider buying registered at those three struggling companies.

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35%-to-45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012 (read more details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Xcerra Corp (NASDAQ:XCRA) had one of its top executives buy shares this past week. President and Chief Executive Officer David G. Tacelli acquired 30,000 shares on Friday at a weighted average cost of $5.17, lifting his overall holding to 1.10 million units of common stock. The company provides test and handling capital equipment, interface products, test fixtures, and services to the semiconductor, industrial, and electronics manufacturing industries. To be more specific, the company mainly offers test solutions to electronics manufacturing companies that use semiconductors and printed circuit board (PCB) test systems as main components. Xcerra Corp (NASDAQ:XCRA)’s shares are down by 35% over the past year, mainly owing to the company’s weak financial performance. Although the stock trades at a relatively cheap trailing price-to-earnings ratio of 16.31 (the ratio is 21.04 for the S&P 500 companies), one should not overlook the company’s disappointing revenue growth in recent quarters. Xcerra’s net sales for the three months that ended October 31 totaled $78.40 million, down from $116.22 million reported a year earlier. The aforementioned valuation metric bears no importance if considering the weakening demand for the company’s products. However, Xcerra’s recent insider buying might suggest that the company is just about to embark on a recovery path, so investors should keep a close eye on the company’s upcoming earnings reports. A total of 19 hedge funds from our system were invested in the company at the end of the third quarter, amassing 14.20% of its shares. Brett Hendrickson’s Nokomis Capital, which owned 2.53 million shares in Xcerra Corp (NASDAQ:XCRA) on September 30, was one of the most bullish investors of Xcerra within our database.

Follow Xcerra Corp (NASDAQ:XCRA)
Trade (NASDAQ:XCRA) Now!

Let’s head to the next two pages of this daily insider trading article, where we discuss the insider buying registered at Earthstone Energy Inc. (NYSEMKT:ESTE) and Esperion Therapeutics Inc. (NASDAQ:ESPR).

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!